Cargando…

Treatment of Patients With HCV Related Cirrhosis: Many Rewards With Very Few Risks

Antiviral treatment of chronic hepatitis C virus (HCV) is aimed at the persistent eradication of the virus, the so-called sustained virological response (SVR), with the aim ultimately being to prevent the development of liver-related complications and improve patients’ survival. Patients with HCV-re...

Descripción completa

Detalles Bibliográficos
Autores principales:	D’Ambrosio, Roberta, Aghemo, Alessio
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Kowsar 2012
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3412551/ https://www.ncbi.nlm.nih.gov/pubmed/22879824 http://dx.doi.org/10.5812/hepatmon.6095

Ejemplares similares

The one, the few and the many
por: Poole, Norman
Publicado: (2020)

Treatment of experienced and naïve patients with hepatitis C: focus on telaprevir
por: D’Ambrosio, Roberta, et al.
Publicado: (2012)

To Our Few Subscribers and Many Readers—Greeting
por: Packard, Francis R.
Publicado: (1935)

If so many are “few,” how few are “many”?
por: Heim, Stefan, et al.
Publicado: (2015)

Osteopathic manipulative treatment for pandemic influenza: many questions, few answers
por: Sanderlin, Brent W, et al.
Publicado: (2007)

Limited Utility of ITPA Deficiency to Predict Early Anemia in HCV Patients with Advanced Fibrosis Receiving Telaprevir
por: Aghemo, Alessio, et al.
Publicado: (2014)

Use of biomarkers in sepsis: many questions, few answers
por: Póvoa, Pedro, et al.
Publicado: (2013)

Medical Men in India: Too Few or Too Many
Publicado: (1947)

From the many to the few: changes in urological cancer surgery provision
por: Nuttall, M, et al.
Publicado: (2005)

Night shift work and sickness absence – many for the few or few for the many?
por: Larsen, A D, et al.
Publicado: (2023)

Mental floss: “Many careers end in success… A few begin with it.”
por: Nichani, Ashish Sham
Publicado: (2011)

Safety and effectiveness of 8 weeks of Glecaprevir/Pibrentasvir in challenging HCV patients: Italian data from the CREST study
por: Aghemo, Alessio, et al.
Publicado: (2023)

HBV and HCV Therapy
por: Lampertico, Pietro, et al.
Publicado: (2009)

The many and the few : political participation in republican Buenos Aires /
por: Sábato, Hilda
Publicado: (2001)

Drugs Many: Remedies Few
Publicado: (1895)

For the Many, Not the Few: Patient Empowerment
por: Horgan, Denis, et al.
Publicado: (2017)

The future of entrepreneurship: the few or the many?
por: Kuratko, Donald F., et al.
Publicado: (2021)

The Association of Il28b Genotype with the Histological Features of Chronic Hepatitis C Is HCV Genotype Dependent
por: D’Ambrosio, Roberta, et al.
Publicado: (2014)

Enhanced recovery after surgery in laparoscopic gastric cancer surgery: Many questions, few answers
por: Shrikhande, Shailesh V., et al.
Publicado: (2014)

Cirrhosis and Rapid Virological Response to Peginterferon Plus Ribavirin Determine Treatment Outcome in HCV-1 IL28B rs12979860 CC Patients
por: Aghemo, Alessio, et al.
Publicado: (2013)

Postpartum depression crisis since the second lockdown and ‘screening paradox’: many women identified, very few treated
por: Chrzan-Dętkoś, Magdalena, et al.
Publicado: (2022)

So Many Are “Few,” but so Few Are Also “Few” – Reduced Semantic Flexibility in bvFTD Patients
por: Heim, Stefan, et al.
Publicado: (2020)

Predicting Hepatocellular Carcinoma Risk in Patients with Chronic HCV Infection and a Sustained Virological Response to Direct-Acting Antivirals
por: D’Ambrosio, Roberta, et al.
Publicado: (2021)

Topical Seminar on Few- and Many-quark Systems
por: Navarria, Francesco Luigi, et al.
Publicado: (1985)

Hepatocellular Carcinoma Risk, Outcomes, and Screening After Hepatitis C Eradication
por: D’Ambrosio, Roberta, et al.
Publicado: (2021)

Risk and reward
por: Kim, Tae-Il
Publicado: (2013)

Trials and tribulations: so many potential treatments, so few answers
por: Gazendam, Aaron, et al.
Publicado: (2020)

Type 1 Diabetes Genes in Rats: Few or Many?
por: Leiter, Edward H.
Publicado: (2009)

Ultrasound-guided tracheostomy - not for the many, but perhaps the few... or the one
por: Tremblay, Lorraine N, et al.
Publicado: (2011)

Simple monetary rules: many strengths and few weaknesses
por: Taylor, John B.
Publicado: (2021)

Why are there so few (or so many) circulating coronaviruses?
por: Rice, Benjamin L., et al.
Publicado: (2021)

Safety and Effectiveness Using 8 Weeks of Glecaprevir/Pibrentasvir in HCV-Infected Treatment-Naïve Patients with Compensated Cirrhosis: The CREST Study
por: Cornberg, Markus, et al.
Publicado: (2022)

Host Genetics Predict Clinical Deterioration in HCV-Related Cirrhosis
por: King, Lindsay Y., et al.
Publicado: (2014)

Reply to: Correspondence on “High rates of 30-day mortality in patients with cirrhosis and COVID-19”
por: Iavarone, Massimo, et al.
Publicado: (2020)

Ribavirin Impairs Salivary gland function During Combination Treatment With Pegylated Interferon Alfa-2a In HEpatitis C patients
por: Aghemo, Alessio, et al.
Publicado: (2011)

A Few Steps Forward, A Few Steps Back
por: Lumpkins, Kimberly M., et al.
Publicado: (2021)

The Trans-Pacific Partnership Agreement and health: few gains, some losses, many risks
por: Labonté, Ronald, et al.
Publicado: (2016)

So many, yet few: Human resources for health in India
por: Rao, Krishna D, et al.
Publicado: (2012)

Chemically Active Particles: From One to Few on the Way to Many
por: Popescu, Mihail N.
Publicado: (2020)

Commentary: Total endoscopic heart surgery: For the few not yet for the many
por: Fudulu, Daniel Paul, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_492s3sgk8htm66ff7itkr9hedf